Identifying patients with multidrug-resistant tuberculosis who may benefit from shorter durations of treatment.
PLoS One
; 18(10): e0292106, 2023.
Article
in En
| MEDLINE
| ID: mdl-37797071
Full text:
1
Collection:
01-internacional
Health context:
2_ODS3
/
3_ND
Database:
MEDLINE
Main subject:
Tuberculosis, Multidrug-Resistant
Type of study:
Observational_studies
/
Prognostic_studies
/
Systematic_reviews
Limits:
Humans
Language:
En
Journal:
PLoS One
Year:
2023
Document type:
Article